business

Zenas BioPharma reports positive phase 3 trial results for obexelimab

Investing.com · Jun 2, 2026, 11:13 PM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss Yahoo Finance Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Zenas BioPharma reports positive phase 3 trial results for obexelimab

Also covered by

More in business